Olivier Govaere

Tenure Track Professor

KU Leuven

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

ORCID

Google Scholar

About

Olivier Govaere is a Tenure Track Professor at KU Leuven in Belgium. His research primarily focuses on liver disease, with particular interest in the roles of adipose tissue macrophages, intestinal B cells, and genetic factors influencing liver injury and disease progression. Recent publications highlight his work on metabolic dysfunction-associated steatotic liver disease and the transcriptomic landscape in patients with decompensated cirrhosis.

Olivier Govaere

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Reply to: “Diabetes-driven pathophysiological remodeling of mesenteric adipose tissue: Transcriptomic insights into macrophage infiltration and adipokine dyshomeostasis”

Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH

Comparison of the single-cell and single-nucleus hepatic myeloid landscape within decompensated cirrhosis patients

Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease

Sublethal necroptosis signaling promotes inflammation and liver cancer.

A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures

Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling

Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with non-alcoholic fatty liver disease.

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.

Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease

Pharmacological testing of therapeutics using normothermic machine perfusion: A pilot study of 2,4-dinitrophenol delivery to steatotic human livers.

Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance.

Transcriptomics Identify Thrombospondin-2 as a Biomarker for Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis.

Key features of the environment promoting liver cancer in the absence of cirrhosis

Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors.

Collaborators (20)

John Lunec

Luca Miele

Jane Grove

Kristian Unger

Fiona Oakley

Ibrahim Al-Naseri

A.G. (Onno) Holleboom

Alastair Burt

Selina Jessica Keppler

Quentin M. Anstee

María José García-Blanco

matthias Lannoo

Tiziana Sanavia

Mirco Castoldi

Rosellina Margherita Mancina

Simon Cockell

Ann Daly

Derek Mann

Ralf Weiskirchen

Antonio Liguori

How do I reach out?

Meet Kite AI